Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac, subtenon triamcinolone, and watch-and-wait for acute pseudophakic macular edema
2016-003232-21Phase 3Terminated
- Sponsor
- Medical University of Graz
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketorolac, triamcinolone acetonide in Irvine-Gass syndrome (IGS), cystoid macular edema (CME), sponsored by Medical University of Graz. Started Oct 2017; status: terminated.
02
Drugs
ketorolactriamcinolone acetonide
03
Conditions
Irvine-Gass syndrome (IGS)cystoid macular edema (CME)
Beyond the preview
Go deeper on 2016-003232-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003232-21.